PI
SIOX

Putnam Investments’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Putnam Investments’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,107
Closed -$491K – 1338
2017
Q1 		$491K Sell
4,107
-466
-10% -$48.8K ﹤0.01% 1111
2016
Q4 		$455K Sell
4,573
-274
-6% -$28.9K ﹤0.01% 1133
2016
Q3 		$543K Buy
+4,847
New +$582K ﹤0.01% 1116

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Putnam Investments's SIOX Position: Q2 2017 in Review

Putnam Investments sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2017, closing a stake of 4,107 shares — an estimated $491K sold.

Putnam Investments first reported a position in SIOX in Q3 2016 and held it in 3 quarters. The position peaked at $543K in Q3 2016. 113 funds tracked by Wall St. Rank hold SIOX as of Q2 2017.

  • Putnam Investments reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Putnam Investments sold 4,107 Sio Gene Therapies Inc. Common Stock shares in Q2 2017, an estimated $491K.
  • Putnam Investments first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2016 and held it in 3 quarters.
  • Putnam Investments's Sio Gene Therapies Inc. Common Stock position peaked at $543K in Q3 2016.
  • 113 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2017.

Based on Putnam Investments's 13F filing for Q2 2017, filed 14 Aug 2017.